Tumor Marker Testing Market Report

Global and Region Tumor Marker Testing Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：214
  • REPORT CODE：GMM947724
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Tumor Marker Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Tumor Marker Testingmarket, defines the market attractiveness level of Tumor Marker Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Tumor Marker Testing industry, describes the types of Tumor Marker Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tumor Marker Testing market and the development prospects and opportunities of Tumor Marker Testing industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tumor Marker Testing market in Chapter 13.

    By Player:

    • Roche Diagnostics Corp

    • BioCurex

    • Hologic, Inc

    • Abbott Diagnostics Ltd, Affymetrix, Inc

    • Dickinson and Company (BD) Diagnostics

    • Clarient, Inc

    • Veridex LLC

    • BioModa, Inc

    • Agilent

    • Technologies, Inc

    • Beckman

    • Correlogic Systems, Inc

    • Gen-Probe, Inc

    • Epigenomics AG

    By Type:

    • Biochemical Markers

    • Oncogenes

    • Growth Factors

    • Hormones

    • Colony Stimulating Factors

    • Lymphokines

    • Immunohistochemical Stains

    • Others

    By End-User:

    • Hospitals

    • Commercial/Private Laboratories

    • Physician Offices/Group Practices

    • Cancer Clinics

    • Ambulatory Care Centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Tumor Marker Testing Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Tumor Marker Testing Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Tumor Marker Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Tumor Marker Testing Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Tumor Marker Testing Market Analysis and Outlook to 2022

    • 7.1 Global Tumor Marker Testing Consumption (2017-2022)

    • 7.2 United States Tumor Marker Testing Consumption (2017-2022)

    • 7.3 Europe Tumor Marker Testing Consumption (2017-2022)

    • 7.4 China Tumor Marker Testing Consumption (2017-2022)

    • 7.5 Japan Tumor Marker Testing Consumption (2017-2022)

    • 7.6 India Tumor Marker Testing Consumption (2017-2022)

    • 7.7 South Korea Tumor Marker Testing Consumption (2017-2022)

    8 Region and Country-wise Tumor Marker Testing Market Analysis and Outlook to 2028

    • 8.1 Global Tumor Marker Testing Consumption Forecast (2022-2028)

    • 8.2 United States Tumor Marker Testing Consumption Forecast (2022-2028)

    • 8.3 Europe Tumor Marker Testing Consumption Forecast (2022-2028)

    • 8.4 China Tumor Marker Testing Consumption Forecast (2022-2028)

    • 8.5 Japan Tumor Marker Testing Consumption Forecast (2022-2028)

    • 8.6 India Tumor Marker Testing Consumption Forecast (2022-2028)

    • 8.7 South Korea Tumor Marker Testing Consumption Forecast (2022-2028)

    9 Global Tumor Marker Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Tumor Marker Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Biochemical Markers Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Oncogenes Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Growth Factors Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Hormones Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Colony Stimulating Factors Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Lymphokines Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Immunohistochemical Stains Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Tumor Marker Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Commercial/Private Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Physician Offices/Group Practices Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cancer Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Ambulatory Care Centers Consumption and Growth Rate (2017-2022)

    10 Global Tumor Marker Testing Market Outlook by Types and Applications to 2028

    • 10.1 Global Tumor Marker Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Biochemical Markers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Oncogenes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Growth Factors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Hormones Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Colony Stimulating Factors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Lymphokines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Immunohistochemical Stains Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Tumor Marker Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Commercial/Private Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Physician Offices/Group Practices Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Cancer Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Ambulatory Care Centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Tumor Marker Testing Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Tumor Marker Testing Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Tumor Marker Testing Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Tumor Marker Testing Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Tumor Marker Testing Market Competitive Analysis

    • 14.1 Roche Diagnostics Corp

      • 14.1.1 Roche Diagnostics Corp Company Details

      • 14.1.2 Roche Diagnostics Corp Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Roche Diagnostics Corp Tumor Marker Testing Product and Service

    • 14.2 BioCurex

      • 14.2.1 BioCurex Company Details

      • 14.2.2 BioCurex Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 BioCurex Tumor Marker Testing Product and Service

    • 14.3 Hologic, Inc

      • 14.3.1 Hologic, Inc Company Details

      • 14.3.2 Hologic, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Hologic, Inc Tumor Marker Testing Product and Service

    • 14.4 Abbott Diagnostics Ltd, Affymetrix, Inc

      • 14.4.1 Abbott Diagnostics Ltd, Affymetrix, Inc Company Details

      • 14.4.2 Abbott Diagnostics Ltd, Affymetrix, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Abbott Diagnostics Ltd, Affymetrix, Inc Tumor Marker Testing Product and Service

    • 14.5 Dickinson and Company (BD) Diagnostics

      • 14.5.1 Dickinson and Company (BD) Diagnostics Company Details

      • 14.5.2 Dickinson and Company (BD) Diagnostics Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Dickinson and Company (BD) Diagnostics Tumor Marker Testing Product and Service

    • 14.6 Clarient, Inc

      • 14.6.1 Clarient, Inc Company Details

      • 14.6.2 Clarient, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Clarient, Inc Tumor Marker Testing Product and Service

    • 14.7 Veridex LLC

      • 14.7.1 Veridex LLC Company Details

      • 14.7.2 Veridex LLC Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Veridex LLC Tumor Marker Testing Product and Service

    • 14.8 BioModa, Inc

      • 14.8.1 BioModa, Inc Company Details

      • 14.8.2 BioModa, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BioModa, Inc Tumor Marker Testing Product and Service

    • 14.9 Agilent

      • 14.9.1 Agilent Company Details

      • 14.9.2 Agilent Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Agilent Tumor Marker Testing Product and Service

    • 14.10 Technologies, Inc

      • 14.10.1 Technologies, Inc Company Details

      • 14.10.2 Technologies, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Technologies, Inc Tumor Marker Testing Product and Service

    • 14.11 Beckman

      • 14.11.1 Beckman Company Details

      • 14.11.2 Beckman Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Beckman Tumor Marker Testing Product and Service

    • 14.12 Correlogic Systems, Inc

      • 14.12.1 Correlogic Systems, Inc Company Details

      • 14.12.2 Correlogic Systems, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Correlogic Systems, Inc Tumor Marker Testing Product and Service

    • 14.13 Gen-Probe, Inc

      • 14.13.1 Gen-Probe, Inc Company Details

      • 14.13.2 Gen-Probe, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Gen-Probe, Inc Tumor Marker Testing Product and Service

    • 14.14 Epigenomics AG

      • 14.14.1 Epigenomics AG Company Details

      • 14.14.2 Epigenomics AG Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Epigenomics AG Tumor Marker Testing Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Tumor Marker Testing

    • Figure Tumor Marker Testing Picture

    • Table Global Tumor Marker Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tumor Marker Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tumor Marker Testing Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Tumor Marker Testing Consumption by Country (2017-2022)

    • Figure United States Tumor Marker Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Tumor Marker Testing Consumption and Growth Rate (2017-2022)

    • Figure China Tumor Marker Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Tumor Marker Testing Consumption and Growth Rate (2017-2022)

    • Figure India Tumor Marker Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Tumor Marker Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Marker Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Tumor Marker Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Tumor Marker Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Tumor Marker Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Tumor Marker Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Tumor Marker Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Tumor Marker Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biochemical Markers Consumption and Growth Rate (2017-2022)

    • Figure Global Oncogenes Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Factors Consumption and Growth Rate (2017-2022)

    • Figure Global Hormones Consumption and Growth Rate (2017-2022)

    • Figure Global Colony Stimulating Factors Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphokines Consumption and Growth Rate (2017-2022)

    • Figure Global Immunohistochemical Stains Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Commercial/Private Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Physician Offices/Group Practices Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Care Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Biochemical Markers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncogenes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormones Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colony Stimulating Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphokines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunohistochemical Stains Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Commercial/Private Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Physician Offices/Group Practices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Care Centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Tumor Marker Testing Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Tumor Marker Testing Export by Region (Top 5 Countries) (2017-2028)

    • Table Roche Diagnostics Corp (Foundation Year, Company Profile and etc.)

    • Table Roche Diagnostics Corp Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Diagnostics Corp Tumor Marker Testing Product and Service

    • Table BioCurex (Foundation Year, Company Profile and etc.)

    • Table BioCurex Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCurex Tumor Marker Testing Product and Service

    • Table Hologic, Inc (Foundation Year, Company Profile and etc.)

    • Table Hologic, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hologic, Inc Tumor Marker Testing Product and Service

    • Table Abbott Diagnostics Ltd, Affymetrix, Inc (Foundation Year, Company Profile and etc.)

    • Table Abbott Diagnostics Ltd, Affymetrix, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Diagnostics Ltd, Affymetrix, Inc Tumor Marker Testing Product and Service

    • Table Dickinson and Company (BD) Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Dickinson and Company (BD) Diagnostics Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dickinson and Company (BD) Diagnostics Tumor Marker Testing Product and Service

    • Table Clarient, Inc (Foundation Year, Company Profile and etc.)

    • Table Clarient, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clarient, Inc Tumor Marker Testing Product and Service

    • Table Veridex LLC (Foundation Year, Company Profile and etc.)

    • Table Veridex LLC Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Veridex LLC Tumor Marker Testing Product and Service

    • Table BioModa, Inc (Foundation Year, Company Profile and etc.)

    • Table BioModa, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioModa, Inc Tumor Marker Testing Product and Service

    • Table Agilent (Foundation Year, Company Profile and etc.)

    • Table Agilent Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Tumor Marker Testing Product and Service

    • Table Technologies, Inc (Foundation Year, Company Profile and etc.)

    • Table Technologies, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Technologies, Inc Tumor Marker Testing Product and Service

    • Table Beckman (Foundation Year, Company Profile and etc.)

    • Table Beckman Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beckman Tumor Marker Testing Product and Service

    • Table Correlogic Systems, Inc (Foundation Year, Company Profile and etc.)

    • Table Correlogic Systems, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Correlogic Systems, Inc Tumor Marker Testing Product and Service

    • Table Gen-Probe, Inc (Foundation Year, Company Profile and etc.)

    • Table Gen-Probe, Inc Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gen-Probe, Inc Tumor Marker Testing Product and Service

    • Table Epigenomics AG (Foundation Year, Company Profile and etc.)

    • Table Epigenomics AG Tumor Marker Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epigenomics AG Tumor Marker Testing Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US